Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

402 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessing the Variability of Cell-Associated HIV DNA Quantification through a Multicenter Collaborative Study.
Le Duff Y, Gärtner K, Busby EJ, Dalzini A, Danaviah S, Fuentes JLJ, Giaquinto C, Huggett JF, Hurley M, Marcellin AG, Muñoz-Fernández MÁ, O'Sullivan DM, Persaud D, Powell L, Rigsby P, Rossi P, de Rossi A, Siems L, Smit T, Watters SA, Almond N, Nastouli E; EPIICAL Consortium. Le Duff Y, et al. Among authors: rossi p, de rossi a. Microbiol Spectr. 2022 Jun 29;10(3):e0024322. doi: 10.1128/spectrum.00243-22. Epub 2022 Jun 6. Microbiol Spectr. 2022. PMID: 35658711 Free PMC article.
Impact of human immunodeficiency virus type 1 subtypes on virologic response and emergence of drug resistance among children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trial.
Pillay D, Walker AS, Gibb DM, de Rossi A, Kaye S, Ait-Khaled M, Muñoz-Fernandez M, Babiker A. Pillay D, et al. Among authors: de rossi a. J Infect Dis. 2002 Sep 1;186(5):617-25. doi: 10.1086/342680. Epub 2002 Aug 9. J Infect Dis. 2002. PMID: 12195348 Clinical Trial.
Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial).
Gibb DM, Walker AS, Kaye S, De Rossi A, Ait-Khaled M, Pillay D, Muñoz-Fernandez MA, Loveday C, Compagnucci A, Dunn DT, Babiker AG. Gibb DM, et al. Among authors: de rossi a. Antivir Ther. 2002 Dec;7(4):293-303. Antivir Ther. 2002. PMID: 12553485 Clinical Trial.
402 results